Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: Developing Drug Products for Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 11, 2014
January 26, 2021
1a25a9e8-1852-4b92-8380-feaa374b8e13
Related Documents
Migraine: Developing Drugs for Preventive Treatment
Guidance DocumentJune 1, 2023Center for Drug Evaluation and Research
Alcoholism: Developing Drugs for Treatment
Guidance DocumentFebruary 12, 2015Center for Drug Evaluation and Research
Endogenous Cushing’s Syndrome: Developing Drugs for Treatment
Guidance DocumentSeptember 8, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.